128 related articles for article (PubMed ID: 12744900)
1. Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity.
Shanley JD; Wu CA
Vaccine; 2003 Jun; 21(19-20):2632-42. PubMed ID: 12744900
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with a replication-deficient adenovirus vector expressing glycoprotein H of murine cytomegalovirus induces mucosal and systemic immunity.
Shanley JD; Wu CA
Vaccine; 2005 Jan; 23(8):996-1003. PubMed ID: 15620472
[TBL] [Abstract][Full Text] [Related]
3. Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.
Wang Z; La Rosa C; Maas R; Ly H; Brewer J; Mekhoubad S; Daftarian P; Longmate J; Britt WJ; Diamond DJ
J Virol; 2004 Apr; 78(8):3965-76. PubMed ID: 15047812
[TBL] [Abstract][Full Text] [Related]
4. Protective MCMV immunity by vaccination of the salivary gland via Wharton's duct: replication-deficient recombinant adenovirus expressing individual MCMV genes elicits protection similar to that of MCMV.
Liu G; Zhang F; Wang R; London L; London SD
FASEB J; 2014 Apr; 28(4):1698-710. PubMed ID: 24391133
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity.
Wilson SR; Wilson JH; Buonocore L; Palin A; Rose JK; Reuter JD
Comp Med; 2008 Apr; 58(2):129-39. PubMed ID: 18524170
[TBL] [Abstract][Full Text] [Related]
6. Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge.
Morello CS; Ye M; Hung S; Kelley LA; Spector DH
J Virol; 2005 Jan; 79(1):159-75. PubMed ID: 15596812
[TBL] [Abstract][Full Text] [Related]
7. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model.
Harrison CJ; Britt WJ; Chapman NM; Mullican J; Tracy S
J Infect Dis; 1995 Nov; 172(5):1212-20. PubMed ID: 7594656
[TBL] [Abstract][Full Text] [Related]
8. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).
Adler SP; Plotkin SA; Gonczol E; Cadoz M; Meric C; Wang JB; Dellamonica P; Best AM; Zahradnik J; Pincus S; Berencsi K; Cox WI; Gyulai Z
J Infect Dis; 1999 Sep; 180(3):843-6. PubMed ID: 10438376
[TBL] [Abstract][Full Text] [Related]
9. Optimization of DNA immunization against human cytomegalovirus.
Endrész V; Burián K; Berencsi K; Gyulai Z; Kari L; Horton H; Virok D; Méric C; Plotkin SA; Gönczöl E
Vaccine; 2001 Jul; 19(28-29):3972-80. PubMed ID: 11427273
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
Lawson CM; Grundy JE; Shellam GR
J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
[TBL] [Abstract][Full Text] [Related]
11. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus.
Gallichan WS; Rosenthal KL
Vaccine; 1995 Nov; 13(16):1589-95. PubMed ID: 8578847
[TBL] [Abstract][Full Text] [Related]
12. Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.
Reap EA; Dryga SA; Morris J; Rivers B; Norberg PK; Olmsted RA; Chulay JD
Clin Vaccine Immunol; 2007 Jun; 14(6):748-55. PubMed ID: 17442845
[TBL] [Abstract][Full Text] [Related]
13. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules.
Eo SK; Gierynska M; Kamar AA; Rouse BT
J Immunol; 2001 May; 166(9):5473-9. PubMed ID: 11313385
[TBL] [Abstract][Full Text] [Related]
14. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
[TBL] [Abstract][Full Text] [Related]
15. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
16. Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines.
Wang JB; Adler SP; Hempfling S; Burke RL; Duliège AM; Starr SE; Plotkin SA
J Infect Dis; 1996 Aug; 174(2):387-92. PubMed ID: 8699071
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity induced by systemic and mucosal delivery of DNA vaccine expressing glycoprotein B of pseudorabies virus.
Yoon HA; Han YW; Aleyas AG; George JA; Kim SJ; Kim HK; Song HJ; Cho JG; Eo SK
J Microbiol Biotechnol; 2008 Mar; 18(3):591-9. PubMed ID: 18388482
[TBL] [Abstract][Full Text] [Related]
18. Recombinant cytomegalovirus glycoprotein gB (UL55) induces an autoantibody response to the U1-70 kDa small nuclear ribonucleoprotein.
Curtis HA; Singh T; Newkirk MM
Eur J Immunol; 1999 Nov; 29(11):3643-53. PubMed ID: 10556820
[TBL] [Abstract][Full Text] [Related]
19. The genotype of mice influences the autoimmune response to spliceosome proteins induced by cytomegalovirus gB immunization.
Lipes J; Skamene E; Newkirk MM
Clin Exp Immunol; 2002 Jul; 129(1):19-26. PubMed ID: 12100018
[TBL] [Abstract][Full Text] [Related]
20. Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
Cardin RD; Bravo FJ; Pullum DA; Orlinger K; Watson EM; Aspoeck A; Fuhrmann G; Guirakhoo F; Monath T; Bernstein DI
Vaccine; 2016 Apr; 34(17):1993-9. PubMed ID: 26973071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
